ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

VTVT vs NRXP // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

vTv Therapeutics Inc. (Class A) (NASDAQ) VS. NRX Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: VTVT 1 — NRXP 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VTVT VS. NRXP) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC VTVT NRXP SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 58.80% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -24.21% -12.25% -11.96 NRXP /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 29.1 30.0 -0.90 NRXP /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $95.5M $94.0M $1.5M VTVT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR VTVT REV NRXP REV VTVT GROSS % NRXP GROSS % VTVT FCF NRXP FCF
FY 2025 $91.9M $1.2M — 58.8% -$25.3M -$14.1M
FY 2024 $1.0M $51.8M — — -$25.3M -$10.6M
FY 2023 $71.4M $77.9M — — -$19.1M -$21.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VTVT // BETA —
NRXP // BETA —